PubRank

Hiroyuki Kobori

Author PubWeight™ 119.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002 3.34
2 Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 2012 2.58
3 Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 2004 2.54
4 Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 2005 2.25
5 Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 2008 2.15
6 Intratubular renin-angiotensin system in hypertension. Hypertension 2011 2.14
7 Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension 2008 2.01
8 Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol 2007 1.99
9 AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol 2005 1.84
10 Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 2006 1.83
11 Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant 2012 1.75
12 Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 2009 1.75
13 Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways. Hypertens Res 2010 1.71
14 Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 2009 1.64
15 Intrarenal AT(1) receptor and ACE binding in ANG II-induced hypertensive rats. Am J Physiol Renal Physiol 2002 1.59
16 Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011 1.58
17 Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension 2013 1.52
18 Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Hypertens Res 2009 1.51
19 The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease. Hypertens Res 2012 1.50
20 Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol 2012 1.48
21 Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 2009 1.43
22 Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells. Am J Hypertens 2011 1.43
23 Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol 2008 1.37
24 Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol 2008 1.34
25 Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant 2010 1.32
26 Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol 2009 1.30
27 Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant 2010 1.29
28 Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am J Physiol Renal Physiol 2011 1.27
29 Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats. Int J Biol Sci 2006 1.27
30 Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens 2010 1.22
31 Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension 2008 1.20
32 Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int 2004 1.20
33 Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy. Biomark Insights 2009 1.17
34 Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol 2007 1.16
35 Collecting Duct Renin: A major player in Angiotensin II-dependent Hypertension. J Am Soc Hypertens 2010 1.14
36 Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation 2012 1.13
37 Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity. Am J Nephrol 2010 1.13
38 Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension. Hypertension 2012 1.12
39 Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 2003 1.10
40 Renal renin-angiotensin system. Contrib Nephrol 2004 1.09
41 Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci 2012 1.08
42 Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J 2012 1.08
43 Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 2011 1.08
44 The growth factor midkine regulates the renin-angiotensin system in mice. J Clin Invest 2009 1.06
45 Tumor necrosis factor-{alpha} suppresses angiotensinogen expression through formation of a p50/p50 homodimer in human renal proximal tubular cells. Am J Physiol Cell Physiol 2010 1.06
46 Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol 2007 1.05
47 Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension 2011 1.05
48 Megalin binds and internalizes angiotensin-(1-7). Am J Physiol Renal Physiol 2005 1.04
49 Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension 2003 1.04
50 Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade. J Hypertens 2010 1.04
51 Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. J Hypertens 2008 1.03
52 IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol 2009 1.03
53 Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy. Int J Mol Sci 2013 1.03
54 AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am J Physiol Renal Physiol 2011 0.99
55 Salt-induced renal injury in SHRs is mediated by AT1 receptor activation. J Hypertens 2011 0.98
56 Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. J Pharmacol Exp Ther 2009 0.98
57 The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep 2012 0.97
58 Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats. Am J Physiol Renal Physiol 2013 0.97
59 Proximal tubular angiotensinogen in renal biopsy suggests nondipper BP rhythm accompanied by enhanced tubular sodium reabsorption. J Hypertens 2012 0.97
60 Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol 2008 0.96
61 Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J Diabetes Investig 2011 0.95
62 Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 2008 0.94
63 Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte. J Hypertens 2010 0.93
64 Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J Hypertens 2011 0.92
65 Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney. J Hypertens 2012 0.92
66 Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension 2011 0.91
67 Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. Am J Hypertens 2012 0.91
68 Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts. J Pharmacol Sci 2011 0.91
69 Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertens Res 2004 0.90
70 Enhanced urinary angiotensinogen excretion in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Med Sci 2010 0.90
71 The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys. Int J Mol Sci 2012 0.89
72 Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. Am J Hypertens 2010 0.89
73 New Generation Calcium Channel Blockers in Hypertensive Treatment. Curr Hypertens Rev 2006 0.88
74 Quantification of human angiotensinogen by a novel sandwich ELISA. Peptides 2006 0.88
75 Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension 2011 0.87
76 Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression. Am J Physiol Renal Physiol 2009 0.86
77 Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity. Metabolism 2010 0.85
78 Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. Gend Med 2012 0.85
79 Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. Int J Clin Med 2011 0.84
80 Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters. J Pharmacol Sci 2009 0.83
81 Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-α in human proximal tubular cells. Clin Exp Pharmacol Physiol 2012 0.82
82 Rho-kinase/nuclear factor-κβ/angiotensinogen axis in angiotensin II-induced renal injury. Hypertens Res 2011 0.82
83 Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature. Hypertension 2012 0.81
84 Add-on aliskiren elicits stronger renoprotection than high-dose valsartan in type 2 diabetic KKAy mice that do not respond to low-dose valsartan. J Pharmacol Sci 2012 0.81
85 Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats. Am J Physiol Renal Physiol 2011 0.81
86 N-type calcium channel inhibition with cilnidipine elicits glomerular podocyte protection independent of sympathetic nerve inhibition. J Pharmacol Sci 2012 0.80
87 Angiotensin II-induced reduction in body mass is Ang II receptor mediated in association with elevated corticosterone. Growth Horm IGF Res 2010 0.80
88 Hypercontrols in genotype-phenotype analysis reveal ancestral haplotypes associated with essential hypertension. Hypertension 2012 0.80
89 Variants and haplotypes in angiotensinogen gene are associated with plasmatic angiotensinogen level in Mexican population. Am J Med Sci 2011 0.80
90 Important aspects of urine sampling for angiotensinogen measurement: time and preservation conditions in healthy individuals. Tohoku J Exp Med 2012 0.79
91 ROCK/NF-κB axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 2014 0.79
92 Role of (pro)renin receptor in Ang II-mediated EGF receptor transactivation. Front Biosci (Elite Ed) 2013 0.79
93 Aldosterone does not contribute to renal p21 expression during the development of angiotensin II-induced hypertension in mice. Am J Hypertens 2011 0.79
94 Aldosterone aggravates glucose intolerance induced by high fructose. Eur J Pharmacol 2013 0.78
95 Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats. PLoS One 2012 0.78
96 Intratubular Renin-Angiotensin System in Hypertension. Curr Hypertens Rev 2006 0.78
97 Calcium channel blocker enhances beneficial effects of an angiotensin II AT1 receptor blocker against cerebrovascular-renal injury in type 2 diabetic mice. PLoS One 2013 0.77
98 Effects of angiotensin II AT₁-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats. J Pharmacol Sci 2013 0.77
99 Short-Term Calorie Restriction in Early Life Attenuates the Development of Proteinuria but Not Glucose Intolerance in Type 2 Diabetic OLETF Rats. ISRN Endocrinol 2011 0.77
100 Roles of Na⁺/H⁺ exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis. J Pharmacol Sci 2013 0.76
101 Renoprotective effects of direct renin inhibition in glomerulonephritis. Am J Med Sci 2014 0.76
102 Regulation of a novel angiotensin II precursor, proangiotensin-12, in the tissues by blockade of the renin-angiotensin system. Hypertens Res 2011 0.75
103 Efficacy of laparoscopic ovarian drilling for polycystic ovary syndrome resistant to clomiphene citrate. J Obstet Gynaecol Res 2007 0.75
104 Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients. Pediatr Nephrol 2014 0.75
105 Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats. J Pharmacol Sci 2013 0.75
106 [Hot topics in renal physiology]. Nihon Jinzo Gakkai Shi 2009 0.75
107 [Intrarenal mechanisms of angiotensin II formation]. Nihon Jinzo Gakkai Shi 2010 0.75
108 Surgery-assisted reproductive technology hybrid therapy: a reproductive procedure for an infertile woman of late reproductive age with multiple myomas. J Obstet Gynaecol Res 2009 0.75
109 Effect of vasopressin on blood flow and RI of the uterine artery during laparoscopic myomectomy. J Minim Invasive Gynecol 2005 0.75
110 OS 15-05 HEPATOCYTE NUCLEAR FACTOR -5 ACTS AS A GLUCOSE-RESPONSIVE ELEMENT OF HUMAN ANGIOTENSINOGEN PROMOTER. J Hypertens 2016 0.75
111 OS 15-05 HEPATOCYTE NUCLEAR FACTOR -5 ACTS AS A GLUCOSE-RESPONSIVE ELEMENT OF HUMAN ANGIOTENSINOGEN PROMOTER. J Hypertens 2016 0.75
112 A new enucleation method for cervical myoma via laparoscopy. J Minim Invasive Gynecol 2006 0.75
113 [The cutting-edge of medicine; progress of research on renin-angiotensin system in chronic kidney disease]. Nihon Naika Gakkai Zasshi 2011 0.75
114 Malignant hyperthermia during a laparoscopic operation. J Minim Invasive Gynecol 2011 0.75